Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy

Add time:07/14/2019    Source:sciencedirect.com

Histone deacetylases (HDACs) are a class of epigenetic modulators with complex functions in histone post-translational modifications and are well known targets for antineoplastic drugs. We have previously developed a series of bisthiazole-based hydroxamic acids as novel potent HDAC inhibitors. In the present work, a new series of bisthiazole-based compounds with different zinc binding groups (ZBGs) have been designed and synthesized. Among them is compound 7, containing a trifluoromethyl ketone as the ZBG, which displays potent inhibitory activity towards human HDACs and improved antiproliferative activity in several cancer cell lines.

We also recommend Trading Suppliers and Manufacturers of 2-(3-Aminophenyl)-5-(trifluoromethyl)pyridine (cas 886361-00-8). Pls Click Website Link as below: cas 886361-00-8 suppliers

Prev:Effect of bulky groups on gas transport properties of semifluorinated poly(ether amide)s containing pyridine moiety
Next:Low dielectric constant and moisture-resistant polyimide aerogels containing trifluoromethyl pendent groups)